USFDA issues 'Form 483' with three observations to Lupin US facility
New Delhi, April 18 (IANS) Major drug maker Lupin on Saturday said that the US health regulator has issued a 'Form 483' ...
New Delhi, April 18 (IANS) Major drug maker Lupin on Saturday said that the US health regulator has issued a 'Form 483' ...
In a groundbreaking development, researchers have engineered a modified version of the CRISPR gene-editing tool. This in...
APCC vice-president Kolanukonda Shivaji raised concern over the Delimitation Bill, 2026, saying the Centre was using red...
The Supreme Court on April 17 refused to entertain a plea of Congress leader Pawan Khera seeking protection against poss...
Washington, Apr 17: U.S. President Donald Trump described his 40-minute phone call with Prime Minister Narendra Modi as ...
The Allahabad High Court has dismissed a petition filed by two Class 12 students seeking to quash an FIR registered agai...
Iran’s Foreign Minister Seyed Abbas Araghchi confirmed that commercial shipping through the strait has resumed as part...
Lagos: Shareholders of Dangote Sugar Refinery Plc have given the green light to a N500 billion rights issue, a move aime...
In early February 2026, markets delivered a powerful reminder of how sensitive industries have become to new development...
Protegrity rolls out AI Team Edition to shield business knowledge during inferencing, using semantic preserving encrypti...